Switzerland
# |
Name |
Free Cash Flow Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.31
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
2 |
USD -0.56
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
3 |
USD -0.68
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
4 |
USD -0.86
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
5 |
USD -0.88
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
6 |
USD -1.49
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
7 |
USD -2.17
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
The Vaccines company in Switzerland with the highest Free Cash Flow Per Share is Basilea Pharmaceutica AG (Swiss Stock Exchange: BSLN.SW) at USD 1.31.
The Vaccines company in Switzerland with the lowest Free Cash Flow Per Share is Molecular Partners AG (Swiss Stock Exchange: MOLN.SW) at USD -2.17.
The top 10 Vaccines companies in Switzerland by Free Cash Flow Per Share are Basilea Pharmaceutica AG, Sandoz Group AG, PolyPeptide Group AG, AC Immune SA, MoonLake Immunotherapeutics, ADC Therapeutics SA and Molecular Partners AG.
The bottom 10 Vaccines companies in Switzerland by Free Cash Flow Per Share are Molecular Partners AG, ADC Therapeutics SA, MoonLake Immunotherapeutics, AC Immune SA, PolyPeptide Group AG, Sandoz Group AG and Basilea Pharmaceutica AG.